Ilan Oren
Président chez ROIVANT SCIENCES LTD.
Fortune : 874 850 $ au 30/04/2024
Postes actifs de Ilan Oren
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ROIVANT SCIENCES LTD. | Independent Dir/Board Member | 01/01/2014 | - |
| Président | 13/03/2023 | - | |
| Directeur/Membre du Conseil | 01/01/2014 | 13/03/2023 | |
Dexcel Pharma Technologies Ltd.
 Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Directeur Général | 10/03/2013 | - |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - | - |
Kriya Therapeutics, Inc.
 Kriya Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kriya Therapeutics, Inc. designs and develops transformative new treatments for prevalent and severe chronic diseases. The company was founded by Shankar Ramaswamy and Roger Jeffs and is headquartered in Redwood City, CA. | Directeur/Membre du Conseil | 01/01/2020 | - |
Clexio Biosciences Ltd.
 Clexio Biosciences Ltd. Pharmaceuticals: OtherHealth Technology Clexio Biosciences Ltd. develops novel therapies for patients suffering from neurological and psychiatric conditions. The private company is based in Jerusalem, Israel. The Israeli company was founded by Elena Kagan, Elisabeth Kogan, Menashe Levy. Elisabeth Kogan has been the CEO since incorporation. | Directeur/Membre du Conseil | 01/01/2018 | - |
| 8400 - The Health Network | Directeur/Membre du Conseil | 01/01/2019 | - |
Historique de carrière de Ilan Oren
Anciens postes connus de Ilan Oren
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SIO GENE THERAPIES INC. | Directeur/Membre du Conseil | 06/06/2018 | 24/09/2020 |
| SIO GENE THERAPIES INC. | Directeur/Membre du Conseil | 01/03/2015 | 21/12/2017 |
| CYNAPSUS THERAPEUTICS INC | Directeur/Membre du Conseil | 09/05/2013 | 21/10/2016 |
| Independent Dir/Board Member | 09/05/2013 | 21/10/2016 | |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | - | - |
Formation de Ilan Oren
| Harvard College | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Israël | 4 |
| Canada | 2 |
Opérationnelle
| Director/Board Member | 9 |
| Independent Dir/Board Member | 3 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ROIVANT SCIENCES LTD. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Cynapsus Therapeutics, Inc.
 Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada. | Health Technology |
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Health Technology |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Clexio Biosciences Ltd.
Clexio Biosciences Ltd. Pharmaceuticals: OtherHealth Technology Clexio Biosciences Ltd. develops novel therapies for patients suffering from neurological and psychiatric conditions. The private company is based in Jerusalem, Israel. The Israeli company was founded by Elena Kagan, Elisabeth Kogan, Menashe Levy. Elisabeth Kogan has been the CEO since incorporation. | Health Technology |
Kriya Therapeutics, Inc.
Kriya Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kriya Therapeutics, Inc. designs and develops transformative new treatments for prevalent and severe chronic diseases. The company was founded by Shankar Ramaswamy and Roger Jeffs and is headquartered in Redwood City, CA. | Commercial Services |
Montes Archimedes Acquisition Corp.
 Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Montes Archimedes Acquisition Corp operates as a blank check company. It is formed for the business purpose to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded James C. Momtazee and Maria C. Walker on July 6, 2020 and is headquartered in Menlo Park, CA. | Finance |
| 8400 - The Health Network |
